Key facts
- This page summarizes Nachum Shamir's Form 4 filing for MediWound Ltd. (MDWD).
- 2 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 12 Nov 2026, 07:34.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Exercise of in-the-money or at-the-money derivative security
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Exercise of in-the-money or at-the-money derivative security
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
Footnote F2
There were no transactions affected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
Footnote F3
The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
Footnote F4
On November 10, 2026, the Reporting Person exercised Series A Warrants to purchase 16,336 ordinary shares at an exercise price of $13.475 per share, paying the aggregate exercise price in cash. The Reporting Person did not sell any of the ordinary shares acquired upon the exercise. No separate price was paid for the Series A Warrants upon exercise. The exercise price is reported in column 2 and in Table I.
SEC remarks
Exhibit 24.1 - Power of Attorney